Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SH) has announced that it recently obtained a Medical Device Registration Certificate (for in vitro diagnostic reagents) issued by the National Medical Products Administration. The product, named Influenza A H1N1 (2009) and Seasonal H3 Subtype Nucleic Acid Detection Kit (Fluorescent PCR Method), is intended for the qualitative detection of nucleic acids from Influenza A H1N1 (2009) and seasonal H3 subtype viruses in human throat swab samples.